CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam
Lund, Sweden – March 25, 2019 - Clinical Laserthermia Systems AB (publ) (CLS) today announced it will be exhibiting and presenting its High Precision, Image-Guided Laser Ablation Solutions at three CME-Accredited Medical Conferences & Workshops in the UK, France, and Netherlands this April 2019. CLS Thermal Therapy products are currently in use at hospitals and clinics in the U.S. and EU for patient treatments and also undergoing several clinical trials. “CLS is excited to be participating in these three medical education